Cost-effectiveness of the use of the continuous subcutaneous insulin infusion pump versus daily multiple injections in type 1 diabetes adult patients at the Mexican Institute of Social Security

Cost-effectiveness of the use of the continuous subcutaneous insulin infusion pump versus daily multiple injections in type 1 diabetes adult patients at the Mexican Institute of Social Security

Abstract Background To estimate the incremental cost-effectiveness ratio (ICER) of the use of continuous subcutaneous insulin infusion (CSII) therapy versus multiple daily injections (MDI) therapy in adult patients with type 1 diabetes (T1D) at the Mexican Institute of Social Security (IMSS). Method...

Full description

Bibliographic Details
Main Authors: Svetlana V. Doubova, Stephane Roze, Aldo Ferreira-Hermosillo, Ricardo Pérez-Cuevas, Ricardo Gasca-Pineda, Casper Barsoe, Jonathan Baran, Brian Ichihara, Erick Gryzbowski, Kyla Jones, Juan E. Valencia
Format: Article
Language:English
Published: BMC 2019-09-01
Series:Cost Effectiveness and Resource Allocation
Subjects:
Continuous subcutaneous insulin infusion
Incremental cost-effectiveness ratio
Type 1 diabetes
Mexico
Online Access:http://link.springer.com/article/10.1186/s12962-019-0187-2

Internet

http://link.springer.com/article/10.1186/s12962-019-0187-2

Similar Items